In a 20‑month‑old child with an isolated elevated alkaline phosphatase, how should the cause be evaluated and managed?

Evaluation and Management of Isolated Elevated Alkaline Phosphatase in a 20-Month-Old

In a 20-month-old with isolated elevated alkaline phosphatase, first exclude X-linked hypophosphatemia (XLH) by checking serum phosphorus, calcium, and PTH; if these are normal and the child is otherwise healthy, the most likely diagnosis is benign transient hyperphosphatasemia (THP), which requires only observation with repeat ALP in 2-4 months.

Initial Diagnostic Approach

Step 1: Assess Clinical Context and Basic Biochemistry

The first priority is distinguishing between pathologic causes requiring intervention and benign conditions:

• Check serum phosphorus, calcium (albumin-adjusted or ionized), and PTH to evaluate for XLH, which presents with hypophosphatemia, normal calcium, and normal or mildly elevated PTH by this age 1, 2
• Review clinical history for recent viral illness, gastroenteritis, fever, acute otitis media, or respiratory infection—these commonly precede THP 3, 4
• Examine for clinical signs of bone disease (lower limb deformity, bone pain, below-average stature) or hepatobiliary disease (jaundice, hepatomegaly, abdominal pain)

Step 2: Interpret the Biochemical Pattern

If phosphorus is LOW for age:

• This suggests XLH, especially if accompanied by elevated or inappropriately normal ALP 1
• By 3 months of age, most infants with XLH demonstrate the classic biochemical profile of hypophosphatemia with increasing ALP 1
• Additional testing should include: serum 25-hydroxyvitamin D, 1,25-dihydroxyvitamin D, FGF23, and TmP/GFR (using age-appropriate normative data) 1
• Genetic testing of the PHEX gene is indicated to confirm XLH diagnosis 1
• Consider skeletal imaging (wrists, knees, ankles) to assess for rachitic changes 1

If phosphorus, calcium, and PTH are NORMAL:

• In an otherwise healthy child with recent viral illness or gastroenteritis, benign transient hyperphosphatasemia is the most likely diagnosis 5, 3
• THP typically occurs in children under 5 years (87% under 24 months), with ALP levels often >1000 U/L (mean 2557 U/L, range 1002-14,589 U/L) 3
• Bone turnover markers (osteocalcin, CrossLaps) remain normal in THP, distinguishing it from true metabolic bone disease 6

Management Algorithm

For Suspected XLH (Hypophosphatemia Present):

Treatment should commence promptly upon confirming XLH diagnosis and hypophosphatemia to optimize outcomes 1:

1. Children ≥12 months: Burosumab is strongly recommended over conventional therapy (active vitamin D and phosphate salts) 1
2. Children 6-12 months: Burosumab is conditionally recommended over conventional therapy 1
3. If burosumab is unavailable, use conventional therapy with active vitamin D (calcitriol 20-50 ng/kg/day or alfacalcidol 25-40 ng/kg/day) combined with phosphate salts (20-60 mg elemental phosphorus/kg/day given 4-6 times daily) 1, 2

For Suspected THP (Normal Phosphorus, Calcium, PTH):

Adopt a "wait and see" approach 5, 3:

• Repeat ALP in 2-4 months to confirm spontaneous resolution 5, 3
• ALP typically normalizes within 4 months without intervention 5, 7
• No additional testing or treatment is needed if the child remains clinically well 3, 6
• Avoid unnecessary investigations, vitamin D treatment, and parental anxiety 3, 6

Critical Pitfalls to Avoid

1. Do not confuse XLH with nutritional rickets: Nutritional rickets presents with low 25-hydroxyvitamin D, decreased calcium AND phosphorus, with substantially elevated PTH (greater than the modest elevation seen in XLH) 1. Nutritional rickets corrects with vitamin D supplementation; XLH does not 1.

2. Do not initiate extensive workup for THP: In a healthy child with isolated ALP elevation and normal phosphorus/calcium/PTH, extensive bone or liver imaging is unnecessary and increases cost and anxiety 5, 3.

3. Use age-appropriate reference ranges: Serum phosphorus, ALP, and TmP/GFR vary significantly with age in childhood—interpretation requires age-specific normative data 1.

4. Recognize the seasonal pattern of THP: Cases peak in autumn-early winter, likely related to increased viral respiratory infections during these months 3, 4.

5. In adults, isolated elevated ALP often indicates serious pathology (57% malignancy in one study 8), but this pattern does NOT apply to young children where THP is common and benign 3.